Dogecoin Cash Business Summary

Dogecoin Cash, Inc. (DOGP) operates as a diversified holding company specializing in the convergence of telemedicine, blockchain technology, and cannabis-related intellectual property. The company generates revenue primarily through transaction-based referral fees from its PrestoDoctor subsidiary—a leading telemedicine platform for medical cannabis evaluations—and the strategic licensing of its patent-pending methods for compliant blockchain-linked security distributions. Its business is divided into three core segments: Telemedicine (PrestoDoctor), Blockchain & Digital Assets (managed through subsidiaries MEME COINS, Inc. and Dogecoin Treasury, Inc.), and Cannabis IP Licensing, which holds patents for specific strains and delivery methods. In the competitive landscape, DOGP contends with specialized telehealth and cannabis technology firms such as Leafly Holdings, Inc., WM Technology, Inc. (Weedmaps), and Syra Health Corp., positioning itself as a pioneer in integrating regulated public market infrastructure with decentralized economic models. Leadership is spearheaded by David Tobias, who serves as Chief Executive Officer, President, and CFO, bringing over a decade of executive experience within the company since its 2005 founding as Cannabis Sativa, Inc. The executive team and board include Treasurer and Director Catherine Carroll, along with Directors Robert N. Tankson and Trevor Reed, who provide oversight on the company's transition into a digital-asset-centric treasury model. Notable strategic influence is also held by major shareholders such as Kyle Powers and institutional interest from entities like Tipestry, Inc., following significant token acquisition agreements in late 2025. This leadership group recently achieved a milestone in January 2026 by completing one of the first FINRA-notified blockchain-linked security distributions in U.S. history, signaling a shift toward high-utility digital asset infrastructure.